Skip to main content
Vai all'homepage della Commissione europea (si apre in una nuova finestra)
italiano it
CORDIS - Risultati della ricerca dell’UE
CORDIS

Protein nanocage-scaffolded proteoliposomes: de novo design of a platform for bacterial vaccines

Descrizione del progetto

Proteoliposomi con nano-cariche proteiche per lo sviluppo di vaccini

I batteri patogeni rappresentano una minaccia significativa per l’assistenza sanitaria e l’economia mondiale. Nel contesto della resistenza antimicrobica, vi è una crescente spinta allo sviluppo di vaccini. Le proteine transmembrana beta-barrel (TMB) dei batteri Gram-negativi sono immunogeni chiave, ma i loro requisiti di ripiegamento unici limitano le opzioni di vaccino. Con il sostegno del programma di azioni Marie Skłodowska-Curie, il progetto ProNanovoVax svilupperà proteoliposomi proteici nano-caricati (PNC-PL) come efficaci piattaforme vaccinali nano-particellari per le TMB. Il progetto utilizzerà strategie avanzate, come la presentazione multi-valente e il targeting immunitario, per ingegnerizzare gli immunogeni TMB sui PNC, creando nanoparticelle vaccinali che assomigliano a virus avvolti. I metodi computazionali saranno utilizzati per progettare ancore transmembrana che ospitano ligandi proteici solubili in grado di riconoscere le cellule immunitarie.

Obiettivo

Pathogenic bacteria pose significant threats to the global healthcare and the economy. Amid growing concerns over antimicrobial resistance, many healthcare programs have pivoted to vaccine development, while new vaccine platforms are in a high demand for disease control and swift responses in the case of health emergencies. A major type of bacterial immunogen is transmembrane beta-barrel (TMB) proteins, which are found on the outer membrane of Gram-negative bacteria and play key roles in virulence. The native folding and trafficking of TMBs requires specific machineries that do not exist in eukaryotic cell membranes. Consequently, there has been few vaccine platforms for TMB immunogens. To address this need, I aim to construct protein nanocage-scaffolded proteoliposomes (PNC-PL) that can act as highly potent nanoparticle vaccine platforms for TMBs. Such nanomaterial will be developed using two cutting-edge strategies in vaccine formulation: multivalent presentation and immune targeting. Combining my strong background in PNC engineering and my host lab’s expertise in TMBs and their computation-assisted design, (1) I will multivalently present computationally engineered TMB immunogens on PNCs in a well-controlled manner, resulting in vaccines composed of PNC-PL nanoparticles that mimic the structures of enveloped viruses. (2) I will design transmembrane anchors using computation-assisted methods to host soluble protein ligands that recognize immune cells. The resultant complexes will be subsequently co-presented with TMB immunogens on PNC-PLs for immune targeting, which will further increase the vaccine potency. (3) With my co-host lab’s rich immunological resources, I will assess immune cell activation induced by the vaccines as a criterion of potency. This novel nanosystem will hold great promise to advance vaccine design with challenging immunogens and serve as a versatile technology for biomaterial design in drug delivery, artificial cells, and other applications.

Campo scientifico (EuroSciVoc)

Parole chiave

Programma(i)

Argomento(i)

Meccanismo di finanziamento

HORIZON-TMA-MSCA-PF-EF - HORIZON TMA MSCA Postdoctoral Fellowships - European Fellowships

Vedi tutti i progetti finanziati nell’ambito di questo schema di finanziamento

Invito a presentare proposte

(si apre in una nuova finestra) HORIZON-MSCA-2024-PF-01

Vedi tutti i progetti finanziati nell’ambito del bando

Coordinatore

VIB VZW
Contributo netto dell'UE
€ 200 400,00
Indirizzo
SUZANNE TASSIERSTRAAT 1
9052 ZWIJNAARDE - GENT
Belgio
Regione
Vlaams Gewest Prov. Oost-Vlaanderen Arr. Gent
Tipo di attività
Research Organisations
Collegamenti
Costo totale
Nessun dato